Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 745–768 of 1,820 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Lymphedema of Leg
Interventions: Pressure; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 30 Years to 75 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Scleroderma, Localized, Morphea, Scleroderma, Circumscribed
Interventions: UVA-1 Phototherapy, Placebo; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 6 Years to 95 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Eating Disorders, Body Image Disturbance, Weight Bias
Interventions: Child Body Image Development Workshop; Behavioral
Lead sponsor: University at Albany; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Albany, New York

Conditions: Test Performance When Distracted or Not
Interventions: TV; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 10 Years to 15 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Autism Spectrum Disorder, Anxiety
Interventions: MB-IMP, Placebo; Drug · Other
Lead sponsor: Southwest Autism Research & Resource Center; Other
Eligibility: 18 Years to 45 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Contraception
Interventions: Emergency contraception website, Emergency contraception video; Other
Lead sponsor: Planned Parenthood League of Massachusetts; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Otitis Media
Interventions: Tympanostomy tube placement, Amoxicillin-Clavulanate and/or Ceftriaxone, Ofloxacin Otic; Device · Drug
Lead sponsor: Alejandro Hoberman; Other
Eligibility: 6 Months to 35 Months
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Pittsburgh, Pennsylvania

Conditions: Otitis Media With Effusion
Interventions: lansoprazole, placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 2 Years to 12 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Posttraumatic Stress Disorder
Interventions: Revisiting the Trauma memories, Processing the trauma memories, Psychoeducation, Trauma Memory Retrieval Trial, Exposure to video clips related to the patient's trauma, Breathing retraining, Exposure Homework, Compound extinction; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: HPV, HPV Associated Cancers, HPV Cancers, Cervical Cancer Screening, Cervical Cancer (Early Detection)
Interventions: Cervical Cancer Screening; Diagnostic Test
Lead sponsor: University of Rochester; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Substance Use, Parenting, Communication
Interventions: Media Ready Parent, Active Control Program; Behavioral
Lead sponsor: Innovation Research & Training; Other
Eligibility: 10 Years and older
Enrollment: 576 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiovascular Disease
Interventions: GSK2212836; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Overweight
Interventions: High dose vegetable juice, Medium dose vegetable juice, Low dose vegetable juice, Control bottled water; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Gastroesophageal Reflux
Interventions: pantoprazole sodium enteric-coated spheroid; Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 1 Year to 5 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 36
States / cities: Mobile, Alabama • Phoenix, Arizona • Oakland, California + 32 more

Conditions: Cardiovascular Risk Stratification, Carotid Intima-media Thickness (CIMT), Stress Echocardiography (SE)
Interventions: Carotid Intima-Media Thickness (CIMT); Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Obesity
Interventions: Social marketing and health promotion campaign; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: Up to 24 Years
Enrollment: 5,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 7
States / cities: Gainesville, Florida • Manhattan, Kansas • Orono, Maine + 4 more

Conditions: Preeclampsia
Interventions: collection of maternal blood specimen prior to delivery, collection of placental cord blood after delivery, collection of placental tissue, collection of strip of decidua from uterine lining from cesarean section deliveries; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Rochester, New York

Conditions: LMNA-Related Dilated Cardiomyopathy
Interventions: NVC-001 - Low Dose, NVC-001 - Intermediate Dose, NVC-001 - High Dose; Genetic
Lead sponsor: Nuevocor Pte. Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 8
States / cities: Birmingham, Alabama • Los Angeles, California • Boston, Massachusetts + 5 more

Conditions: Sleep Quality
Interventions: Risk Stratification, Usual Care; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Progressive Aphasia
Interventions: high-definition transcranial direct current stimulation, modified constraint-induced language therapy; Device · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 45 Years to 80 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Aging
Interventions: Abdominal subcutaneous adipose tissue biopsy; Procedure
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Oropharyngeal Dysphagia
Interventions: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR), Placebo; Biological · Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Sacramento, California • San Francisco, California

Conditions: Chronic Kidney Disease, Pulmonary Embolism, Renal Artery Stenosis, Pulmonary Cancer
Interventions: Low Volume iso-osmolar non-ionic radio contrast medium, Acetylcysteine Inhalation, Sodium Bicarbonate Solution, 64-MDCT Scanning; Drug · Procedure
Lead sponsor: VA Greater Los Angeles Healthcare System; Federal
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Frontotemporal Dementia
Interventions: LY3884963, Methylprednisolone, Optional Sirolimus, Optional Prednisone; Biological · Drug
Lead sponsor: Prevail Therapeutics; Industry
Eligibility: 30 Years to 85 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 4
States / cities: Maitland, Florida • Orlando, Florida • Burlington, Massachusetts + 1 more

Search by objective public record fields.

Establishing Guidelines for Manual Lymphatic Drainage

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development

Media Background and Test Performance

Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults

Targeted Video Messaging About Emergency Contraception

Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media

A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion

Enhancing Exposure Therapy for Post-traumatic Stress Disorder

Emergency Department-based Cervical Cancer Screening Through Self-sampling

Feasibility Study of a Web-based Program to Help Parents of Middle School Students Effectively Communicate With Their Children About Substance Use

An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.

The Juice Study: Sensitivity of Skin Carotenoid Status to Detect Change in Intake

Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification

Get Fruved: Obesity Prevention for Older Adolescents

Gene Expression In Pregnancies Complicated by Preeclampsia

A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring

Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS

Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants

Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)